What is VNT's health score?

Vontier Corp (VNT) has a TradeApes health score of 55 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is VNT's estimated fair value?

Based on our 5-year discounted cash flow model, Vontier Corp's estimated fair value is $13.92 per share, representing a -50.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is VNT undervalued or overvalued?

Our model currently rates VNT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for VNT... Refresh in a moment for the full analysis.

Vontier Corp (VNT)

Healthcare Overvalued high mixed

$28.15

Updated: 2026-06-05

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

45 Mixed

Relative Value

55 Mixed

Capital Allocation

70 Healthy

Risk

70 Healthy

Est. Fair Value $13.92

DCF Upside -50.6%

Sector Rank #3558 of 6674

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.